Cumberland Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.5% | 17.7% | 14.3% | 19.3% | 19.3% | 18.5% | 17.8% | 15.0% | 17.2% | 21.2% | 16.8% | 17.4% | 18.5% | 20.6% | 19.6% | 27.2% | 23.2% | 22.1% | 22.9% | 19.2% | 16.5% | 40.0% | 19.8% | 19.7% | 19.5% | 29.0% | 13.6% | 14.0% | 17.5% | 16.4% | 18.5% | 17.4% | 14.6% | 18.9% | 12.2% | 18.6% | 11.9% | 16.4% | 21.2% | 22.5% | 16.6% | |
| 77.5% | 82.3% | 85.7% | 80.7% | 80.7% | 81.5% | 82.2% | 85.0% | 82.8% | 78.8% | 83.2% | 82.6% | 81.5% | 79.4% | 80.4% | 72.8% | 76.8% | 77.9% | 77.1% | 80.8% | 83.5% | 60.0% | 80.2% | 80.3% | 80.5% | 71.0% | 86.4% | 86.0% | 82.5% | 83.6% | 81.5% | 82.6% | 85.4% | 81.1% | 87.8% | 81.4% | 88.1% | 83.6% | 78.8% | 77.5% | 83.4% | |
| 7.3% | 12.8% | 9.3% | 12.5% | 8.4% | 8.4% | 21.8% | 14.3% | 15.4% | 19.9% | 10.6% | 12.6% | 12.3% | 18.1% | 20.7% | 14.8% | 13.3% | 13.6% | 11.9% | 15.0% | 18.0% | 19.4% | 15.6% | 17.7% | 15.0% | 15.4% | 16.3% | 10.5% | 19.1% | 13.5% | 13.6% | 10.8% | 14.4% | 12.4% | 11.1% | 13.5% | 15.1% | 11.3% | 16.0% | 463.9% | 16.1% | |
| 21.2% | 30.2% | 21.9% | 27.2% | 18.7% | 29.8% | 27.1% | 23.0% | 24.4% | 27.2% | 22.4% | 21.8% | 23.4% | 20.0% | 24.4% | 22.8% | 25.7% | 35.0% | 21.2% | 23.2% | 25.3% | 41.0% | 20.6% | 21.4% | 19.0% | 38.4% | 27.1% | 21.8% | 23.2% | 36.8% | 27.9% | 28.0% | 29.4% | 31.9% | 21.0% | 26.5% | 31.0% | 29.5% | 28.0% | 1,530.5% | 37.5% | |
| 76.1% | 92.9% | 92.5% | 100.1% | 88.1% | 89.3% | 110.8% | 93.6% | 104.1% | 95.5% | 84.7% | 87.8% | 99.3% | 86.7% | 102.5% | 89.3% | 89.9% | 94.9% | 80.1% | 96.6% | 102.9% | 112.4% | 91.8% | 98.2% | 83.0% | 95.9% | 103.1% | 85.8% | 101.0% | 149.7% | 103.5% | 93.1% | 104.1% | 98.7% | 76.8% | 88.3% | 111.8% | 93.6% | 113.1% | 1,976.2% | 114.2% | |
| 1.5% | -10.5% | -6.8% | -19.4% | -7.5% | -7.8% | -28.6% | -8.5% | -21.3% | -16.8% | -1.5% | -5.2% | -17.8% | -7.3% | -22.2% | -16.5% | -13.1% | -17.0% | -3.1% | -15.9% | -19.4% | -52.3% | -11.6% | -17.9% | -2.5% | -25.0% | -16.6% | 0.2% | -18.5% | -66.1% | -22.0% | -10.4% | -18.6% | -17.7% | 11.0% | -6.9% | -23.7% | -10.0% | -34.3% | -1,898.7% | -30.8% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 1.0% | 0.5% | 0.8% | 0.6% | 0.2% | 0.4% | 1.2% | 0.8% | 0.3% | 0.2% | 0.3% | 0.2% | 0.3% | 1.1% | 1.3% | 1.3% | 2.0% | 2.0% | 1.8% | 1.1% | 1.9% | 1.4% | 1.3% | 1.5% | 2.1% | 1.4% | 1.0% | 1.3% | 0.8% | 0.9% | 0.4% | 1.0% | |
| 1.7% | -10.4% | -6.6% | -18.9% | -6.7% | -7.2% | -27.8% | -7.3% | -19.5% | -16.5% | -1.0% | -4.9% | -18.9% | -7.2% | -22.2% | -17.4% | -13.7% | -17.3% | -3.3% | 8.1% | -19.5% | -52.6% | -12.5% | -13.2% | -3.6% | -26.4% | 1.9% | 8.0% | -10.5% | -67.1% | -22.3% | -11.1% | -16.8% | -18.8% | 10.7% | -6.7% | -23.4% | -10.3% | -34.4% | -1,862.5% | -30.7% | |
| 0.7% | -1.9% | 6.8% | 40.8% | 0.0% | -0.2% | 0.0% | 0.0% | 0.0% | 0.0% | -0.7% | 0.0% | 0.0% | 0.0% | 0.4% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.5% | 0.1% | 0.1% | 0.1% | 0.3% | 0.1% | 0.1% | 0.1% | -0.5% | 0.0% | 0.1% | 0.1% | 0.2% | 0.0% | 2.3% | 0.1% | |
| 1.2% | -8.3% | -13.2% | -59.5% | -6.6% | -6.9% | -27.7% | -7.1% | -19.3% | -16.4% | -0.6% | -4.7% | -18.8% | -7.0% | -12.7% | -9.6% | -5.2% | -8.6% | 1.6% | 13.6% | -13.1% | -46.2% | -12.4% | -13.0% | -3.6% | -26.8% | 2.1% | 8.0% | -10.4% | -67.3% | -22.9% | -11.0% | -17.0% | -18.2% | 10.7% | -6.8% | -23.4% | -10.3% | -34.4% | -2,472.5% | -33.9% | |
| 9.0% | -3.3% | 0.6% | -11.1% | -0.8% | -1.3% | -19.5% | -0.2% | -10.9% | -9.1% | 8.5% | 5.4% | -20.2% | 1.3% | -8.0% | -3.9% | -0.1% | -5.0% | 8.6% | 21.9% | -6.0% | -39.3% | 3.4% | 3.9% | 11.2% | -18.9% | 19.4% | 23.5% | 5.4% | -43.1% | -4.0% | 4.7% | 0.1% | 0.4% | 23.3% | 6.5% | -6.2% | 0.3% | -16.3% | -1,876.2% | -16.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.